SDC1 and congestive heart failure: Several studies have investigated syndecan-1 [22,23,24,25,26,27,28] and -4 [29,30,31,32] as potential circulating biomarkers in heart disease, with a focus on ischemia and MI, dilated cardiomyopathy (DCM), and acute and chronic heart failure.